US Stock MarketDetailed Quotes

SLS Sellas Life Sciences

Watchlist
  • 1.460
  • -0.010-0.68%
Close May 17 16:00 ET
  • 1.480
  • +0.020+1.37%
Post 19:59 ET
84.32MMarket Cap-1351P/E (TTM)

Sellas Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.26%-10.76M
-31.92%-31.41M
6.35%-4.83M
-19.94%-6.89M
-31.33%-7.57M
-69.61%-12.13M
8.50%-23.81M
-3.54%-5.15M
2.25%-5.75M
-17.62%-5.76M
Net income from continuing operations
13.80%-9.57M
9.59%-37.34M
10.80%-8.14M
-31.97%-9.27M
-5.06%-8.84M
33.73%-11.1M
-99.53%-41.3M
-38.24%-9.12M
0.89%-7.02M
-82.40%-8.41M
Operating gains losses
----
88.89%-4K
--0
--0
95.83%-2K
-118.18%-2K
-140.00%-36K
106.82%3K
93.33%-2K
-271.43%-48K
Other non cash items
58.62%138K
-95.13%495K
372.34%128K
-37.76%122K
578.79%158K
-99.13%87K
344.02%10.16M
98.97%-47K
40.00%196K
-124.63%-33K
Change In working capital
-9.31%-1.81M
-40.70%3.35M
-24.70%2.69M
172.73%1.71M
-73.56%604K
-97.73%-1.66M
174.08%5.64M
636.98%3.57M
-23.72%627K
421.24%2.28M
-Change in prepaid assets
-65.60%-2.44M
-90.98%113K
-7.22%694K
11.93%544K
-44.16%349K
-143.23%-1.47M
206.73%1.25M
-25.72%748K
295.18%486K
-16.78%625K
-Change in payables and accrued expense
968.18%764K
-22.82%3.75M
-27.90%2.12M
267.90%1.3M
-43.61%419K
-110.76%-88K
372.06%4.86M
966.47%2.95M
-67.13%352K
132.96%743K
-Change in other current liabilities
-41.94%-132K
-9.98%-518K
-3.94%-132K
38.86%-129K
-95.24%-164K
-89.80%-93K
-157.38%-471K
30.60%-127K
---211K
---84K
Cash from discontinued investing activities
Operating cash flow
11.26%-10.76M
-31.92%-31.41M
6.35%-4.83M
-19.94%-6.89M
-31.33%-7.57M
-69.61%-12.13M
8.50%-23.81M
-3.54%-5.15M
2.25%-5.75M
-17.62%-5.76M
Investing cash flow
Cash flow from continuing investing activities
-22.22%-5.5M
0
-3M
-4.5M
0
0
Net intangibles purchase and sale
----
-22.22%-5.5M
--0
---3M
----
----
---4.5M
--0
--0
----
Cash from discontinued investing activities
Investing cash flow
----
-22.22%-5.5M
--0
---3M
----
----
---4.5M
--0
--0
----
Financing cash flow
Cash flow from continuing financing activities
40.95%26.65M
-7.33%22.32M
264.48%3.39M
-49.53%54K
-100.13%-29K
40,121.28%18.9M
99.43%24.08M
1,758.00%929K
-95.23%107K
239.07%23M
Net common stock issuance
40.82%26.55M
-7.37%22.23M
266.31%3.4M
--0
-100.13%-29K
--18.85M
166.45%23.99M
--929K
-96.92%69K
--23M
Proceeds from stock option exercised by employees
88.68%100K
42.35%121K
--14K
42.11%54K
--0
12.77%53K
-97.23%85K
--0
1,800.00%38K
--0
Net other financing activities
----
---31K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
40.95%26.65M
-7.33%22.32M
264.48%3.39M
-49.53%54K
-100.13%-29K
40,121.28%18.9M
99.43%24.08M
1,758.00%929K
-95.23%107K
239.07%23M
Net cash flow
Beginning cash position
-84.73%2.63M
-19.72%17.23M
-81.03%4.07M
-48.66%13.91M
67.24%24M
-19.72%17.23M
-39.40%21.46M
-18.70%21.45M
-9.76%27.09M
-48.99%14.35M
Current changes in cash
134.40%15.89M
-245.04%-14.6M
65.92%-1.44M
-74.46%-9.84M
-179.27%-10.1M
195.41%6.78M
69.67%-4.23M
14.27%-4.22M
-55.09%-5.64M
575.96%12.74M
End cash Position
-22.86%18.52M
-84.73%2.63M
-84.73%2.63M
-81.03%4.07M
-48.66%13.91M
67.24%24M
-19.72%17.23M
-19.72%17.23M
-18.70%21.45M
-9.76%27.09M
Free cash flow
11.26%-10.76M
-30.38%-36.91M
6.35%-4.83M
-72.15%-9.89M
1.90%-10.07M
-69.61%-12.13M
-8.79%-28.31M
-3.54%-5.15M
2.25%-5.75M
-109.49%-10.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.26%-10.76M-31.92%-31.41M6.35%-4.83M-19.94%-6.89M-31.33%-7.57M-69.61%-12.13M8.50%-23.81M-3.54%-5.15M2.25%-5.75M-17.62%-5.76M
Net income from continuing operations 13.80%-9.57M9.59%-37.34M10.80%-8.14M-31.97%-9.27M-5.06%-8.84M33.73%-11.1M-99.53%-41.3M-38.24%-9.12M0.89%-7.02M-82.40%-8.41M
Operating gains losses ----88.89%-4K--0--095.83%-2K-118.18%-2K-140.00%-36K106.82%3K93.33%-2K-271.43%-48K
Other non cash items 58.62%138K-95.13%495K372.34%128K-37.76%122K578.79%158K-99.13%87K344.02%10.16M98.97%-47K40.00%196K-124.63%-33K
Change In working capital -9.31%-1.81M-40.70%3.35M-24.70%2.69M172.73%1.71M-73.56%604K-97.73%-1.66M174.08%5.64M636.98%3.57M-23.72%627K421.24%2.28M
-Change in prepaid assets -65.60%-2.44M-90.98%113K-7.22%694K11.93%544K-44.16%349K-143.23%-1.47M206.73%1.25M-25.72%748K295.18%486K-16.78%625K
-Change in payables and accrued expense 968.18%764K-22.82%3.75M-27.90%2.12M267.90%1.3M-43.61%419K-110.76%-88K372.06%4.86M966.47%2.95M-67.13%352K132.96%743K
-Change in other current liabilities -41.94%-132K-9.98%-518K-3.94%-132K38.86%-129K-95.24%-164K-89.80%-93K-157.38%-471K30.60%-127K---211K---84K
Cash from discontinued investing activities
Operating cash flow 11.26%-10.76M-31.92%-31.41M6.35%-4.83M-19.94%-6.89M-31.33%-7.57M-69.61%-12.13M8.50%-23.81M-3.54%-5.15M2.25%-5.75M-17.62%-5.76M
Investing cash flow
Cash flow from continuing investing activities -22.22%-5.5M0-3M-4.5M00
Net intangibles purchase and sale -----22.22%-5.5M--0---3M-----------4.5M--0--0----
Cash from discontinued investing activities
Investing cash flow -----22.22%-5.5M--0---3M-----------4.5M--0--0----
Financing cash flow
Cash flow from continuing financing activities 40.95%26.65M-7.33%22.32M264.48%3.39M-49.53%54K-100.13%-29K40,121.28%18.9M99.43%24.08M1,758.00%929K-95.23%107K239.07%23M
Net common stock issuance 40.82%26.55M-7.37%22.23M266.31%3.4M--0-100.13%-29K--18.85M166.45%23.99M--929K-96.92%69K--23M
Proceeds from stock option exercised by employees 88.68%100K42.35%121K--14K42.11%54K--012.77%53K-97.23%85K--01,800.00%38K--0
Net other financing activities -------31K--------------------------------
Cash from discontinued financing activities
Financing cash flow 40.95%26.65M-7.33%22.32M264.48%3.39M-49.53%54K-100.13%-29K40,121.28%18.9M99.43%24.08M1,758.00%929K-95.23%107K239.07%23M
Net cash flow
Beginning cash position -84.73%2.63M-19.72%17.23M-81.03%4.07M-48.66%13.91M67.24%24M-19.72%17.23M-39.40%21.46M-18.70%21.45M-9.76%27.09M-48.99%14.35M
Current changes in cash 134.40%15.89M-245.04%-14.6M65.92%-1.44M-74.46%-9.84M-179.27%-10.1M195.41%6.78M69.67%-4.23M14.27%-4.22M-55.09%-5.64M575.96%12.74M
End cash Position -22.86%18.52M-84.73%2.63M-84.73%2.63M-81.03%4.07M-48.66%13.91M67.24%24M-19.72%17.23M-19.72%17.23M-18.70%21.45M-9.76%27.09M
Free cash flow 11.26%-10.76M-30.38%-36.91M6.35%-4.83M-72.15%-9.89M1.90%-10.07M-69.61%-12.13M-8.79%-28.31M-3.54%-5.15M2.25%-5.75M-109.49%-10.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg